Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1651539

registered interest
date	10/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with representatives from the pharmaceutical industry on new drugs for dementia care.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	193107
answer	answer is ministerial correction date of answer 13/07/2023 answer text <p>The Government regularly engages with industry leaders and companies bringing new medicines and technologies to market in high priority clinical areas, including dementia. The Medicines and Healthcare products Regulatory Agency, the National Institute for Health and Care Excellence and NHS England will liaise with individual companies as potential new medicines for the treatment of dementia are considered through the established licensing and appraisal processes. The Government encourages companies to engage constructively in the established processes to support patient access to safe and effective new medicines in a way that represents value to the National Health Service.</p> answering member constituency Colchester answering member printed Will Quince question first answered 13/07/2023 15:52:34 answering member 4423 label Biography information for Will Quince
tabling member	4131 label Biography information for Jim Shannon

1651139

registered interest
date	07/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Insomnia: Melatonin
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether melatonin gummies are licensed for use on the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	192987
answer	answer is ministerial correction date of answer 13/07/2023 answer text <p>There are no melatonin gummy products licensed in the United Kingdom. Therefore, there is currently no prescribing of these products reimbursable by the National Health Service. While no recent discussions between the Medicines and Healthcare products Regulatory Agency (MHRA) and my Rt hon. Friend, the Secretary of State for Health and Social Care, on the potential use of melatonin gummies by the NHS have occurred, the MHRA are looking at the reclassification of the products where melatonin may feature as a section of the Primary Care Recovery Plan.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 192988 question first answered 13/07/2023 09:13:24 answering member 4423 label Biography information for Will Quince
tabling member	4131 label Biography information for Jim Shannon

1651140

registered interest
date	07/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Insomnia: Melatonin
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has had recent discussions with the MHRA on the potential use of melatonin gummies by the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	192988
answer	answer is ministerial correction date of answer 13/07/2023 answer text <p>There are no melatonin gummy products licensed in the United Kingdom. Therefore, there is currently no prescribing of these products reimbursable by the National Health Service. While no recent discussions between the Medicines and Healthcare products Regulatory Agency (MHRA) and my Rt hon. Friend, the Secretary of State for Health and Social Care, on the potential use of melatonin gummies by the NHS have occurred, the MHRA are looking at the reclassification of the products where melatonin may feature as a section of the Primary Care Recovery Plan.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 192987 question first answered 13/07/2023 09:13:24 answering member 4423 label Biography information for Will Quince
tabling member	4131 label Biography information for Jim Shannon

1651141

registered interest
date	07/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Insomnia: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether melatonin gummies have been prescribed for children on the NHS; and if he will make a statement.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	192989
answer	answer is ministerial correction date of answer 13/07/2023 answer text <p>There currently are no melatonin gummy products licensed in the United Kingdom. Therefore, there will be no prescribing of these products for children reimbursable by the National Health Service. That said, the Medicines and Healthcare products Regulatory Agency (MHRA) is reviewing the reclassification of products where melatonin may feature as a section of the Primary Care Recovery Plan.</p> answering member constituency Colchester answering member printed Will Quince question first answered 13/07/2023 09:15:21 answering member 4423 label Biography information for Will Quince
tabling member	4131 label Biography information for Jim Shannon

1651142

registered interest
date	07/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Insomnia: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of prescribing melatonin gummies for sleep disorders in children.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	192990
answer	answer is ministerial correction date of answer 13/07/2023 answer text <p>There currently are no melatonin gummy products licensed in the United Kingdom. The Medicines and Healthcare products Regulatory Agency (MHRA) will review and advise on the benefits and risks for a given medicine when marketing authorisation applications are received for specific products with the appropriate clinical data. Currently there are no products submitted and since the MHRA’s remit does not extend to soliciting such applications, it cannot make an assessment of the potential merits of prescribing melatonin gummies for sleep disorders in children.</p><p> </p> answering member constituency Colchester answering member printed Will Quince question first answered 13/07/2023 09:17:32 answering member 4423 label Biography information for Will Quince
tabling member	4131 label Biography information for Jim Shannon

1651177

registered interest
date	07/07/2023
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Undocumented Migrants
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, what steps she is taking to collaborate with devolved Governments on tackling illegal migration.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	193000
answer	answer is ministerial correction date of answer 17/07/2023 answer text <p>Immigration is a reserved matter and representatives from across Government meet with their counterparts and will continue to do so as part of regular engagement with the Devolved Administrations.</p><p>The Home Secretary chaired the Home Office’s Interministerial Group with the Devolved Administrations on 11th July 2023, where one of the items for discussion was the Illegal Migration Bill.</p> answering member constituency Newark answering member printed Robert Jenrick question first answered 17/07/2023 09:11:59 answering member 4320 label Biography information for Robert Jenrick
tabling member	4131 label Biography information for Jim Shannon

1650328

registered interest
date	05/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Incontinence: Products
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the answer of 1 June 2023 to Question 186357 on Incontinence: Products, how the most economically advantageous tender approach in relation to procurement of absorbent continence products takes into account (a) whole system costs, and (b) item pricing; and what steps he is taking to help ensure the approach (i) does not deter product innovation, (ii) does not adversely impact patient quality of life and health outcomes, (iii) decrease resilience in the supply chain and (iv) incur additional costs.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	192523
answer	answer is ministerial correction date of answer 10/07/2023 answer text <p>The NHS Supply Chain have a disposable continence framework in place which runs until August 2025. All suppliers are awarded onto the framework, with evaluation based on the most economically advantageous tender (MEAT). Financial and non-financial evaluations are undertaken independently of each other. When a trust selects a supplier, the trust will evaluate potential suppliers on the framework, evaluating the subjective, qualitative features of ease of use, comfort, comparative reduction in leakages, quality of life and health outcomes.</p><p>NHS Supply Chain are currently in the process of working on two separate value-based procurement projects, both of which aim to concentrate on leaks, reduction in mobility, loss of dignity, reduction in quality of life, or risk of skin infections and pressure ulcers.</p><p>The Government's new Medical Technology Strategy, published in February 2023, set out how the health and social care system can reliably access safe, effective and innovative medical technologies that support the continued delivery of high-quality care, outstanding patient safety and excellent patient outcomes in a way that makes the best use of taxpayer money. To deliver value for money and affordability across the whole patient pathway, DHSC, NHS Supply Chain and NHS England are building on work to develop a consistent methodology for value-based procurement of innovative products.</p> answering member constituency Colchester answering member printed Will Quince question first answered 10/07/2023 09:22:23 answering member 4423 label Biography information for Will Quince
tabling member	4131 label Biography information for Jim Shannon

1650330

registered interest
date	05/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Respiratory Syncytial Virus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has a timescale for approval and rollout of vaccines protecting against respiratory syncytial virus.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	192524
answer	answer is ministerial correction date of answer 14/07/2023 answer text <p>Policy options based on the Joint Committee on Vaccination and Immunisation’s advice on a potentially expanded respiratory syncytial virus vaccination programme are being developed. This includes the Department working with the UK Health Security Agency and NHS England on implementation, with NHS England leading on delivery.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 14/07/2023 10:47:46 answering member 4492 label Biography information for Maria Caulfield
tabling member	4131 label Biography information for Jim Shannon

1650331

registered interest
date	05/07/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Strokes: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve aftercare for stroke patients.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	192525
answer	answer is ministerial correction date of answer 13/07/2023 answer text <p>On 24 November 2022, the Chancellor of the Duchy of Lancaster published a Written Ministerial Statement noting that departments had been instructed to take a series of actions relating to surveillance equipment subject to the National Intelligence Law of the People’s Republic of China. This Department has been implementing this policy along with other protective security controls.</p><p>At Report Stage of the Procurement Bill, the Government committed that, within six months of Royal Assent, the Government will set out the timeline for the removal of surveillance equipment supplied by companies subject to the National Intelligence Law of China from sensitive sites. This Department will be providing information to the Cabinet Office to support this commitment. It is a longstanding Government policy that specific security arrangements regarding Government estates are withheld on security grounds.</p><p> </p> answering member constituency Colchester answering member printed Will Quince question first answered 13/07/2023 09:23:55 answering member 4423 label Biography information for Will Quince
tabling member	4131 label Biography information for Jim Shannon

1650332

registered interest
date	05/07/2023
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Bank Services: Vulnerable Adults
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Chancellor of the Exchequer, what recent steps his Department is taking to help ensure vulnerable groups have access to cash and in-person banking services.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	192526
answer	answer is ministerial correction date of answer 10/07/2023 answer text <p>The government recognises that while the transition towards digital banking and payments brings opportunities, cash and in-person services continue to be used by many people, including those who may be in vulnerable groups, across the UK.</p><p> </p><p>The government has recently legislated through the Financial Services and Markets Act 2023 to establish a new legislative framework to protect access to cash. The Act establishes the Financial Conduct Authority (FCA) as the lead regulator for access to cash with responsibility and powers to seek to ensure reasonable provision of cash withdrawal and deposit facilities. As part of this, the FCA must also seek to ensure that there is reasonable provision of free cash withdrawal and deposit facilities in relation to personal current accounts.</p><p> </p><p>Decisions on opening and closing branches are a commercial issue, and the government does not intervene in these. However, the FCA’s guidance expects firms to carefully consider the impact of any planned closure on their customers’ everyday banking and cash access needs and consider possible alternative access arrangements for those who rely on in-person services. In particular, the FCA expects firms to analyse the needs and characteristics of customers in vulnerable circumstances currently using the sites. This includes known protected characteristics such as age or disability.</p><p> </p><p>In the context of the government’s access to cash legislation, the financial services sector is working together to develop and provide shared services. To date, industry has committed to over 100 shared cash access services, including over 60 banking hubs. People can also access cash and everyday banking services via their local Post Office.</p> answering member constituency Arundel and South Downs answering member printed Andrew Griffith question first answered 10/07/2023 13:20:10 answering member 4874 label Biography information for Andrew Griffith
tabling member	4131 label Biography information for Jim Shannon